Riskpilot← Back to searchSign inGet full accessOpgen ApS
APSIn liquidationCVR 27913741Store Kongensgade 68Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20041 employees
Revenue 2020
DKK -81K
-122% vs 2019
EBITDA margin
334.9%
+63% vs 2019
Equity ratio
-67.5%
Financial strength
Net profit 2020
DKK -81K
+90% vs 2019
| Revenue | DKK -81K | -122% |
| EBITDA | DKK -273K | +63% |
| Net profit | DKK -81K | +90% |
| Total assets | DKK 5,2M | -4% |
| Equity | DKK -3,5M | -2% |
| Employees | 1 | — |
Legal name
Opgen ApS
CVR number
27913741
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17. juni 2004
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Store Kongensgade 68
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -694 | -474 | 827 | 211 | -230 | 408 | 332 | 366 | -81 |
| Staff expenses | -9.604 | -1.464 | -937 | -914 | -1.082 | -1.019 | -1.054 | -1.112 | -191 |
| EBITDA | -10.298 | -1.938 | -110 | -703 | -1.312 | -610 | -722 | -745 | -273 |
| Depreciation & amort. | -138 | -80 | -71 | -26 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10.436 | -2.018 | -181 | -728 | -1.312 | -610 | -722 | -745 | -273 |
| Net financials | -963 | -3.490 | -284 | -278 | -43 | 198 | -118 | -43 | 191 |
| Profit before tax | -11.398 | -5.508 | -465 | -1.006 | -1.355 | -412 | -840 | -788 | -81 |
| Tax | -411 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -10.987 | -5.508 | -465 | -1.006 | -1.355 | -412 | -840 | -788 | -81 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.335 | 2.697 | 3.434 | 1.546 | 655 | 653 | 6.118 | 5.432 | 5.225 |
| Equity | -110.531 | 382 | -84 | -49 | -1.404 | -1.816 | -2.656 | -3.444 | -3.526 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 112.867 | 2.316 | 3.517 | 1.595 | 2.059 | 2.470 | 8.774 | 8.877 | 8.751 |
| Total debt | 112.867 | 2.316 | 3.517 | 1.595 | 2.059 | 2.470 | 8.774 | 8.877 | 8.751 |
EBITDA margin
-27258500.0%
This company
15.8%
Market median
-172522252% vs market
20122020
Equity ratio
-67.5%
This company
38.2%
Market median
-277% vs market
20122020
Return on equity
-8147600.0%
This company
18.4%
Market median
-44280535% vs market
20122020
Net profit margin
-8147600.0%
This company
8.1%
Market median
-100587754% vs market
20122020
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122020
Debt / equity
2.48×
This company
0.62×
Market median
-300% vs market
20122020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TT Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
TC Management | Management | 2017 | — | — |
KF Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
DH Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
Ai Founder | Founder | 2004 | — | — |
MN Unofficial title | Unofficial title | 2021 | — | — |
DB Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2004 | — | — | |
| Chairman | 2005 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Opgen ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thais Taaning Johansen | Chief Executive Officer | 0 companies |
| Timothy Carroll Dec | Management | 0 companies |
| Kevin F. Krenitsky | Chief Executive Officer | 0 companies |
| Dennis H. Langer | Chief Executive Officer | 0 companies |
| AdvanDx inc | Founder | 0 companies |
| Morten Neergaard | Unofficial title | 0 companies |
| Donald Bruce Hawthorne | Chief Executive Officer | 0 companies |
| Evan Jones | Chairman | 0 companies |
| Ingelise Saunders | Board of Directors | 0 companies |
| Marianne Sigfusson | Chairman | 0 companies |
| Jack Taaning Johansen | Chairman | 0 companies |
| Hans Ulrik Andreassen | Chairman | 0 companies |
| Thomas Patrick Kelly | Board of Directors | 0 companies |
| Vadim Michael Sapiro | Board of Directors | 0 companies |
| Christopher Dawber Earl | Board of Directors | 0 companies |